GOLQEMZI Trademark

Trademark Overview


On Friday, February 23, 2024, a trademark application was filed for GOLQEMZI with the United States Patent and Trademark Office. The USPTO has given the GOLQEMZI trademark a serial number of 98418212. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, September 3, 2024. This trademark is owned by Celgene Corporation. The GOLQEMZI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for human use.
golqemzi

General Information


Serial Number98418212
Word MarkGOLQEMZI
Filing DateFriday, February 23, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for human use.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543

Trademark Events


Event DateEvent Description
Friday, February 23, 2024NEW APPLICATION ENTERED
Friday, February 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 28, 2024ASSIGNED TO EXAMINER
Tuesday, September 3, 2024NON-FINAL ACTION E-MAILED
Tuesday, September 3, 2024NON-FINAL ACTION WRITTEN
Tuesday, September 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED